Carbamazepine: A Therapy for ADHD

J Gordon Millichap

doi:10.15844/pedneurbriefs-10-3-5

Carbamazepine: A Therapy for ADHD

Pediatric Neurology Briefs

Volume 10 (1996): Issue 3

By: J Gordon Millichap

Open Access

|Mar 1996

Abstract

The efficacy of carbamazepine (CBZ) in treatment of ADHD has been determined by meta-analysis of 10 reports from the international literature reviewed at Columbia University, St Luke’s-Roosevelt Hospital Center, and New York University Medical Center.

References

Silva RR Munoz DM Alpert M Carbamazepine use in children and adolescents with features of attention-deficit hyperactivity disorder: a meta-analysis J Am Acad Child Adolesc Psychiatry 1996 Mar 35 3 352 8 10.1097/00004583-199603000-00017 8714324
Open DOI Search in Google Scholar Back to article
Chen YJ Kang WM So WC Comparison of antiepileptic drugs on cognitive function in newly diagnosed epileptic children: a psychometric and neurophysiological study Epilepsia 1996 Jan 37 1 81 6 10.1111/j.1528-1157.1996.tb01849.x 8603630
Open DOI Search in Google Scholar Back to article
Lee DO Steingard RJ Cesena M Helmers SL Riviello JJ Mikati MA Behavioral side effects of gabapentin in children Epilepsia 1996 Jan 37 1 87 90 10.1111/j.1528-1157.1996.tb01856.x 8603631
Open DOI Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.15844/pedneurbriefs-10-3-5 | Journal eISSN: 2166-6482

Journal RSS Feed

Language: English

Page range: 20 - 21

Published on: Mar 1, 1996

Published by: Pediatric Neurology Briefs Publishers

In partnership with: Paradigm Publishing Services

Keywords:

Carbamazepine,

Motor Overactivity,

Impulsivity

© 1996 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 10 (1996): Issue 3